World must drastically accelerate AIDS efforts or face more HIV infections and deaths than five years ago—says UNAIDS and Lancet Commission

UNAIDS and Lancet Commission

New report ‘Defeating AIDS–Advancing global health’ shows that innovations in the AIDS response should be exploited to meet future global health challenges.   

Countries most affected by HIV must focus on stopping new HIV infections and expanding access to antiretroviral treatment or risk the epidemic rebounding, urges a major new report from the UNAIDS and Lancet Commission.

“We must face hard truths—if the current rate of new HIV infections continues, merely sustaining the major efforts we already have in place will not be enough to stop deaths from AIDS increasing within five years in many countries,” said Professor Peter Piot, Director of the London School of Hygiene & Tropical Medicine, Co-Chair of the Commission, and lead author of the report. “Expanding sustainable access to treatment is essential, but we will not treat ourselves out of the AIDS epidemic. We must also reinvigorate HIV prevention efforts, particularly among populations at highest risk, while removing legal and societal discrimination.”

While unprecedented progress has been made to increase access to HIV treatment globally, the report shows that the rate of new HIV infections is not falling fast enough. This, combined with high demographic growth in some of the most affected countries, is increasing the number of people living with HIV who will need antiretroviral therapy to stay alive.   

“We have to act now. The next five years provide a fragile window of opportunity to fast-track the response and end the AIDS epidemic by 2030,” said Michel Sidibé, Executive Director of UNAIDS and Co-Convenor of the Commission. “If we don’t, the human and financial consequences will be catastrophic.”  

While there is scope in many countries for greater shared responsibility by increasing funding for HIV, the report clearly shows the urgent need for substantial global solidarity to front-load investments. The need for investment is particularly acute in low-income countries with a high HIV burden.

Among the sobering findings from the report is that sustaining current HIV treatment and prevention efforts would require up to 2% of GDP, and at least a third of total government health expenditure, in the most affected African countries from 2014 to 2030 to fund HIV programmes. This clearly demonstrates that international support to the AIDS efforts in these countries will be needed for many years to come. However, there is also a pressing need to ensure that people are not left behind in middle-income countries, which can and must do more to sustain their HIV prevention and care programming in higher risk, often marginalised populations.

If the most is made of this five-year window of opportunity, HIV transmission and AIDS-related deaths could be greatly reduced and mother-to-child transmission virtually eliminated by 2030. This will not only require an increase in resources, but also a more strategic and efficient use of those resources.

HIV programmes have a maximum effect when used in combinations that are tailored to the needs and contexts of populations at higher risk and in geographical locations with high HIV prevalence, as is now the policy in countries such as Kenya. At the same time, synergies with mainstream health services are needed, and a long-term view to ensure sustainability of achievements, including high quality antiretroviral treatment.

Also recognising extraordinary innovation in the AIDS response, the Commission calls for leveraging lessons learned in the AIDS response to be applied to new and existing global health challenges.

“The movement created by the AIDS response is unprecedented—a system of checks and balances from a people-centred approach is one that more global health institutions should adopt. Identifying multi-sectoral stakeholders early will save time and money by ensuring the best solutions reach the right people,” said Lancet Editor-in-Chief and Co-Convenor of the Commission Dr Richard Horton.

The report is critical of countries that have become complacent, highlighting that some countries with previously stable or declining HIV epidemics have shown trends of increasing risky sexual behaviours among at-risk groups over the past five years, with new HIV infections on the rise. For example, recent studies have found clear evidence of resurgent HIV epidemics among men who have sex with men in Western Europe, North America, and Asia. In Uganda, national trends in new HIV infections have started to reverse and rise again after a decade of growing successes, in part because of a decreased focus on HIV prevention.

The report makes seven key recommendations, leading with the urgent need to scale up AIDS efforts, get serious about HIV prevention, and continue expanding access to treatment. Other recommendations include efficient mobilisation of more resources for HIV prevention, treatment, and research, and for robust, transparent governance and accountability for HIV and health. The AIDS response must continue to be grounded in human rights, and practical solutions are needed to expedite changes in laws, policies, and attitudes that violate the rights of vulnerable populations, and that stand in the way of an effective AIDS response.

The UNAIDS and Lancet Commission

The Commission, which was established in early 2013 by UNAIDS and The Lancet, brings together 38 Heads of State and political leaders, HIV and health experts, young people, activists, scientists, and private sector representatives to ensure that lessons learned in the AIDS response can be applied to transform how countries and partners approach health and development.

Co-Chairs

  • H.E. Joyce Banda, Former President of the Republic of Malawi
  • Dr Nkosazana Dlamini Zuma, Chair of the African Union Commission
  • Professor Peter Piot, Director of the London School of Hygiene & Tropical Medicine

Report ‘Defeating AIDS–Advancing global health’: www.thelancet.com/commissions/defeating-aids-advancing-global-health

June 25, 2015
Year of publication
2015
Tags
AIDS response, global health, access to treatment, antiretroviral therapy, ARVs, ART, AIDS, treatment, HIV prevention, HIV, antiretroviral drugs, UNAIDS, HIV infections, HIV programmes

Similar Resources

The Global Fund OVC Programme specifically aimed to work towards the achievement of one of the goals of the Global Fund Phase II Grant - that is, to reduce the number of new HIV infections by at least 50% using combination prevention approaches.

In this report we assess who pays for cooperation in global health through an analysis of the financial flows of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, TB and Malaria, and Gavi, the Vaccine Alliance.

Without addressing HIV-related stigma and discrimination, the world will not achieve the goal of ending AIDS as a public health threat by 2030.

Controlling the HIV Epidemic with Antiretrovirals - Having the Courage of Our Convictions

DREAMS is an ambitious $385 million partnership to reduce HIV infections among adolescent girls and young women in 10 sub-Saharan African countries. The goal of DREAMS is to help girls develop into Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe women.

Much has changed since the global HIV community convened at the previous International AIDS conference in Durban in 2016.

The Global Technical Strategy for Malaria 2016–2030 was adopted by the World Health Assembly in May 2015. It provides a comprehensive framework to guide countries in their efforts to accelerate progress towards malaria elimination.

Use this interactive map to connect with other programs implementing HIPs and to learn from each other’s successes and challenges. Developed with support from the U.S.

This document includes:
 
  • A Strategic Development Summary (SDS) narrative communicating the epidemiologic and country/regional context; methods used for programmatic design; findings of integrated data analysis; and strategic direction for the investments and programs…